Almac has teamed up with Welsh Academics and industrial chemistry firm Hockley International to develop enzymes capable of making drug intermediates more quickly.
BioTrove is taking aim at the drug development sector with its RapidFire 300 absorption, distribution, metabolism, and elimination (ADME) screening system that, it claims, can analyse samples in a fraction of the time taken by traditional HPLC.
EPIDAUROS Biotechnologie has acquired a non-exclusive licence for
the diagnostic use of one of the most important genetic variants of
the cytochrome P450 2D6 gene.